US 10220029
Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
granted A61KA61K31/454A61P
Quick answer
US patent 10220029 (Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases) held by OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/454, A61P, A61P1/00, A61P1/04